C-Term GRP polyclonal antibody

Rabbit polyclonal antibody against total GRP, all carboxylation forms

Ref PA:T50 · 50 µg · €360

Snapshot

Catalog numberPA:T50
TargetTotal GRP, all forms
Host and clonalityRabbit, polyclonal
ReactivityMulti-species, fish to mammals
ApplicationsWestern blot, immunolocalization, immunofluorescence, flow cytometry, immunogold electron microscopy
Quantity and form50 µg, lyophilized
PurityAffinity purified
Storage-20 °C short term, -80 °C long term

What it is for

GRP is a vitamin K-dependent protein with 15 putative γ-carboxyglutamic acid residues in humans. It inhibits calcification in the cardiovascular and articular systems and acts as an anti-inflammatory agent in several cell types. It is present in serum and accumulates at sites of pathological calcification.

PA:T50 recognizes GRP independently of carboxylation state and reacts across species from fish to mammals. It shows no significant cross-reactivity with other Gla-containing proteins such as matrix Gla protein and osteocalcin.

  • Detecting, localizing and characterizing total GRP across tissues, cells, nanoparticles, extracellular vesicles and protein extracts

Confirmed species reactivity

SpeciesValidated by
HumanWestern blot, vascular system; immunolocalization, several tissues
RatWestern blot, skin; immunolocalization, several tissues
MouseWestern blot, skin
PigWestern blot, skin and elastic cartilage
RabbitWestern blot, skin
SturgeonWestern blot, purified GRP protein

Validated applications

ApplicationRecommended concentration
Western blot5 µg/ml
Immunolocalization5 µg/ml

Optimize for your application.

Handling

Reconstitute with 50 µL sterile protease-free water, by gentle rotation at 4 °C for at least 12 hours.

Shipped at room temperature, lyophilized.

After reconstitution store at -20 °C for up to two months. For long term storage use -80 °C.

Avoid repeated freeze-thaw cycles.

Key references

  • Viegas CS et al. (2009). Gla-rich protein is a novel vitamin K-dependent protein present in serum and accumulated at sites of pathological calcifications. Am J Pathol 175(6):2288-2298. https://doi.org/10.2353/ajpath.2009.090474
  • Viegas CSB et al. (2018). Chronic kidney disease circulating calciprotein particles and extracellular vesicles promote vascular calcification: a role for GRP. Arterioscler Thromb Vasc Biol 38(3):575-587. https://doi.org/10.1161/ATVBAHA.117.310578
  • Viegas C et al. (2026). Bioengineered baculovirus-derived extracellular vesicles loaded with γ-carboxylated Gla-rich protein: dual modulation of inflammation and vascular calcification. Biomater Adv 184:214833. https://doi.org/10.1016/j.bioadv.2026.214833

The complete reference list is in the datasheet.

For research use only. Not intended for diagnostic, therapeutic or commercial use. Based on PCT patent application PCT/PT2009000046, owned by the University of Algarve and CCMAR, licensed to GenoGla Diagnostics.

Related products